Send us a text

🎧 From Dye Pots to Blockbusters: The Bayer Story
In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead takes you on a journey through Bayer’s 160+ year evolution, from its 1863 roots in coal tar dyes to becoming the maker of Aspirin 💊, Xarelto ❤️, and Eylea 👁️. We explore how a dye salesman and a master dyer built a pharma empire, the game-changing invention of Aspirin, blockbuster therapies, the turbulent Monsanto acquisition 🌾⚖️, and the company’s high-stakes reinvention under CEO Bill Anderson.

🧬 Science, strategy, and resilience — Bayer’s story is biotech history in motion.

🎙️ Tune in for a 30-min deep dive into one of the world’s most iconic life science companies.

#Bayer #Biotech #PetriDishPerspectives #BiotechPodcast #ScienceStorytelling #BillAnderson #HealthcareLeadership

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

In this episode of Petri Dish Perspectives: Biotech Unleashed, we journey through the 165+ year saga of Bristol Myers Squibb (BMS) — from 19th-century Brooklyn apothecaries and sparkling laxatives 💊 to cutting-edge CAR-T therapies and checkpoint inhibitors in cancer treatment 🧫🔥.

Host Manead, a PhD scientist in cancer biology and analytical chemistry, breaks down:

📜 The parallel founding stories of E.R. Squibb & Sons and Bristol-Myers
 🧠 The game-changing 1989 merger that created BMS
 ❤️ Blockbuster hits in cardiovascular health (Plavix, anyone?)
 🧪 The leap into immuno-oncology with Opdivo and Yervoy
🧲 The bold $74B acquisition of Celgene — and how it supercharged BMS’s cell therapy pipeline
🚀 What’s next in AI-driven R&D, off-the-shelf CAR-Ts, and more

If you’re curious how a legacy pharma reinvented itself into an oncology and biotech juggernaut, this episode is for you.

🎧 Grab your favorite drink and tune in to explore the science, the strategy, and the standout leaders behind BMS.

#PetriDishPerspectives #BiotechUnleashed #BMS #Immunotherapy #CAR_T #PharmaHistory #Oncology #BiotechPodcast

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

Ever wonder how an oil conglomerate helped create one of the world’s top pharma giants? 💥 In this episode of Petri Dish Perspectives: Biotech Unleashed, your host, Manead, dives into the fascinating story of Sanofi, a company whose name you’ve probably seen on insulin pens 💉, flu shots 🦠, and blockbuster immunology meds 💊.

We explore:
 🔹 Sanofi’s wild beginnings inside a French oil giant 🛢️
 🔹 Game-changing acquisitions — Aventis, Genzyme, and more 💸
 🔹 Lantus and its dominance in diabetes care 🧃
 🔹 Vaccine legacy from Louis Pasteur to COVID-19 🧫
 🔹 The Dupixent boom and Regeneron partnership 🤝
 🔹 Bold bets on mRNA 🧬 and AI 🔍 in drug discovery
 🔹 CEO Paul Hudson’s tech-first transformation 🚀

Whether you’re into biotech strategy, pharma history, or future-forward science, this 30-minute episode has something for every science nerd and healthcare junkie out there 🔬💡

🎧 Grab your favorite drink, hit play, and geek out with us!

#biotech #pharma #Sanofi #healthcareinnovation #podcast #PetriDishPerspectives

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

In this episode of Petri Dish Perspectives: Biotech Unleashed, we'll take you on a 350-year journey through the rise of Merck — from its humble beginnings as a family-run pharmacy in 17th-century Germany to becoming one of the world’s most influential pharmaceutical powerhouses.

We’ll explore how Merck evolved through groundbreaking discoveries like streptomycin, the MMR vaccine, statins, and the game-changing cancer immunotherapy Keytruda. You’ll also hear about the incredible legacy of Dr. Maurice Hilleman, a vaccine pioneer whose work continues to save millions of lives today.

Along the way, we dive into Merck’s unique split post-WWI, its relentless focus on science-first innovation, and its modern-day ventures in oncology, gene editing, and AI-driven drug discovery.

Whether you’re a biotech enthusiast, healthcare professional, or just curious about the companies shaping tomorrow’s medicine, this episode packs powerful insights in under 30 minutes. Grab your coffee and settle in — this is Merck, unleashed.

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

🐴 From Farmyard Roots to Pharma Powerhouse: The Boehringer Ingelheim Story 🐴

Welcome to Petri Dish Perspectives: Biotech Unleashed! 🚀 I’m your host, Manead—scientist and biotech nerd.

Today, we’re spotlighting Boehringer Ingelheim—a family-owned pharma giant that began in a small German village and grew into one of the world’s top 20 pharmaceutical companies. From veterinary vaccines to life-saving treatments for respiratory disease, diabetes, and cancer, Boehringer has quietly shaped medicine for humans and animals alike.

They’ve stayed private for over 135 years—what’s their secret? How did a rural chemist’s workshop become a global leader in immuno-oncology and regenerative medicine? And where is Boehringer placing its bets for the future?

Grab your notebook—or your favorite biotech-friendly beverage—and join me as we explore the fascinating rise of Boehringer Ingelheim. 💊

🎧 Listen now and unleash your inner biotech geek!

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the rich history and groundbreaking innovations of Johnson & Johnson (J&J)—one of the most influential healthcare companies in the world. From its origins in the late 19th century as a family-run surgical supply business to becoming a household name with products like Band-Aids, Tylenol, and Johnson’s Baby Powder, J&J has shaped modern medicine in countless ways.

We’ll explore how Robert Wood Johnson I, alongside his brothers, turned a struggling startup into a global powerhouse by pioneering antiseptic surgical techniques, mass-market first-aid products, and cutting-edge medical devices. Along the way, we’ll also discuss J&J’s resilience through major challenges—like the 1982 Tylenol crisis, which redefined corporate crisis management.

Fast forward to today, and J&J is still at the forefront of innovation, investing heavily in robotics, gene therapy, and AI-driven healthcare solutions. 

🎧 Grab a coffee and tune in for a fast-paced, insightful breakdown of J&J's journey!

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

In this episode of Petri Dish Perspectives: Biotech Unleashed, we explore the rise of AbbVie, a pharmaceutical giant that emerged from Abbott Laboratories in 2013 and quickly became a leader in immunology, oncology, and aesthetics.

From its blockbuster drug Humira to major acquisitions like Pharmacyclics and Allergan, AbbVie has strategically expanded its portfolio and global presence. We’ll break down the company’s history, key milestones, and the vision driving its future—including cutting-edge research in neuroscience and gene therapy.

Join me as we uncover the science, business moves, and leadership decisions that have shaped AbbVie into one of the most influential players in biotech today.

🎧 Grab a coffee and tune in for a fast-paced, insightful breakdown of AbbVie’s journey!

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

Welcome to Petri Dish Perspectives: Biotech Unleashed! In this episode, we dive deep into the history and impact of Eli Lilly, a company that began with a small lab in Indianapolis and has grown into the highest market-cap pharmaceutical company in the world.

From pioneering insulin production in the 1920s to developing blockbuster drugs like Prozac, Humalog, and Mounjaro, Eli Lilly has played a crucial role in shaping modern medicine. We’ll explore the founding story, key scientific breakthroughs, and the company’s ongoing commitment to innovation in diabetes, neuroscience, and oncology.

Join me as we break down how Lilly continues to push the boundaries of biotech and what the future holds for this pharmaceutical giant. Grab a coffee, settle in, and let’s geek out on the science behind one of the most influential names in healthcare!

🎧 Subscribe, share, and stay curious! 🚀

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

💊 From Brooklyn to Biotech Titan: The Rise of Pfizer 💊

Welcome to the first-ever episode of Petri Dish Perspectives: Biotech Unleashed! 🚀 I’m your host, Manead—scientist, biotech nerd, and your guide through the fascinating world of life sciences.

We’re kicking things off with Pfizer—a company that started as a small chemical business in Brooklyn and grew into a global powerhouse. From upscaling penicillin in WWII to revolutionizing cholesterol treatment with Lipitor, turning a failed heart drug into Viagra, and spearheading the COVID-19 vaccine, Pfizer has been at the forefront of medical breakthroughs for 175 years.

How did two German cousins build a billion-dollar empire? What made Pfizer a leader in R&D, and where are they headed next? Grab a coffee (or your favorite lab-safe beverage) and dive in as we break it all down. 🧪🔬

🎧 Listen now and unleash your inner biotech geek!

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.